✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Ind-Swift Laboratories Ltd.

INDSWFTLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹1,261 Cr.
P/E
5.07

Ind-Swift Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
1,261 Cr
PE
PE
5.07
Prom Holding
Prom Holding
39.50 %
ROE (%)
ROE (%)
21.35
ROCE (%)
ROCE (%)
3.20
Div Yield (%)
Div Yield (%)
-
Sales
Sales
594 Cr
OPM (%)
OPM (%)
0.01 %
Debt to Equity
Debt to Equity
0.03
View more
Edit Ratio's

About

Ind-Swift Laboratories Ltd, a public limited company established in 1995, is a global manufact… Read more
Low
69
52W Range
High
152
  • Ind-Swift Lab.
  • Lincoln Pharma
  • Syncom Formulations

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

10 %
(as of Mar 20)
Source/Historic
Atorvastatin (Digestive) - Market Share
25 %
(as of Mar 20)
Source/Historic
Clarithromycin (Respiratory) - Market Share
15 %
(as of Mar 20)
Source/Historic
Clopidogrel (Cardio) - Market Share
8 %
(as of Mar 20)
Source/Historic
Ezetimibe (Cardio) - Market Share
20 %
(as of Mar 20)
Source/Historic
Fexofenadine (Anti-Allergic) - Market Share
25 %
(as of Mar 20)
Source/Historic
Ivabradine (Cardio) - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Total reactor capacity (kL)
      Source
    • DMF Filingsby API (.)
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    FAQs on Ind-Swift Laboratories Ltd. Business

    Ind-Swift Laboratories Ltd, based in Chandigarh, India, is a global manufacturer of APIs, Intermediates, and formulations. Established in 1995, the company focuses on API manufacturing and is a key player in the Indian pharmaceutical industry.

    Ind-Swift Lab. major competitors are Lincoln Pharma, Syncom Formulations, Sakar Healthcare, Jagsonpal Pharma, Kwality Pharma, Beta Drugs, Venus Remedies.
    Market Cap of Ind-Swift Lab. is ₹1,286 Crs.
    While the median market cap of its peers are ₹1,144 Crs.

    Ind-Swift Lab. seems to be less financially stable compared to its competitors.
    Altman Z score of Ind-Swift Lab. is 5.2 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Feb Mar
    Investor Presentation Jan Feb Jun Sep
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material